Skip to main content

MRK

Merck & Co., Inc.
ShareXLinkedInReddit
Sector
Health Care
Industry
Pharmaceuticals
Last price
$123.54
As of

Active signals for MRK

  • highTRIAL_TERMINATION

    Phase 3 trial terminated early — Merck A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately

  • highTRIAL_TERMINATION

    Phase 3 trial terminated early — Merck Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic

  • highTRIAL_TERMINATION

    Phase 3 trial terminated early — Merck Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (P

  • highTRIAL_TERMINATION

    Phase 3 trial terminated early — Merck A Weight Maintenance Study in Obese Patients (0364-012)(TERMINATED)

  • mediumEARNINGS_BEAT

    Q3-2025: Beat consensus by 13.1% — EPS $2.68 vs $2.3705 estimate

Top institutional holders of MRK (13F)

FundMarket value% portfolioQoQ
MILLENNIUM MANAGEMENT LLC$715.8M0.30%+745.7%
CITADEL ADVISORS LLC$410.6M0.06%+0.8%
CITADEL ADVISORS LLC$324.6M0.05%,
MILLENNIUM MANAGEMENT LLC$237.1M0.10%-71.0%
TWO SIGMA INVESTMENTS, LP$165.3M0.25%,
D. E. Shaw & Co., Inc.$104.4M0.06%+25.9%
D. E. Shaw & Co., Inc.$72.6M0.04%-17.0%
D. E. Shaw & Co., Inc.$69.8M0.04%,
MILLENNIUM MANAGEMENT LLC$67.5M0.03%,
Bridgewater Associates, LP$43.1M0.17%,
Bridgewater Associates, LP$32.7M0.12%-39.6%
Point72 Asset Management, L.P.$8.3M0.01%+11.2%
TWO SIGMA INVESTMENTS, LP$6.7M0.01%+303.6%
Point72 Asset Management, L.P.$6.5M0.01%+30.4%
Point72 Asset Management, L.P.$4M0.01%,
TWO SIGMA INVESTMENTS, LP$1.4M0.00%-99.3%

Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.

Recent SEC filings, MRK

Related tickers

See more MRK signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track MRK in your watchlist and get notified the moment a new signal fires.

Track MRK on Kresmion →